Abstract: The present invention relates to shaped articles which are suitable for controlling Varroa mites in bees.

Abstract: The invention relates to a device for examining the infestation of honey bee colonies with Varroa mites. The device contains a container with a bottom, side walls and a cover. Within the container there is a means which causes the Varroa mites to drop off the bees, but does not harm the bees, and a means for fixing the dropped Varroa mites to the bottom of the container. The invention furthermore relates to a method of examining the degree of infestation of honey bee colonies with Varroa mites using the device according to the invention, and to a method for examining the sensitivity of the Varroa mites of a bee colony to various acaricid-containing active compounds using the device according to the invention.

Abstract: The present invention relates to the use of macrocyclic lactones for treating demodicosis, particularly in dogs.

Abstract: The present invention relates to shaped articles which are suitable for controlling Varroa mites in bees.

Abstract: The invention relates to a device for examining the infestation of honey bee colonies with Varroa mites. The device contains a container with a bottom, side walls and a cover. Within the container there is a means which causes the Varroa mites to drop off the bees, but does not harm the bees, and a means for fixing the dropped Varroa mites to the bottom of the container. The invention furthermore relates to a method of examining the degree of infestation of honey bee colonies with Varroa mites using the device according to the invention, and to a method for examining the sensitivity of the Varroa mites of a bee colony to various acaricid-containing active compounds using the device according to the invention.

Abstract: The present invention relates firstly to the discovery of the previously unknown 24-membered cyclooctadepsipeptides PF1022-V, PF1022-W, XRB-C894, XRB-C942, XRB-C976, XRB-C1010, XRB-C1044, XRB-E922, XRB-E956, XRB-E990, XRB-E1024, XRB-S958, XRB-S992, XRB-S1026, XRB-S1060 (in various isomeric forms) and to the processes for the preparation of the abovementioned cyclooctadepsipeptides by means of the fungal strains from the family Xylariaceae, in particular the genera Rosellinia and Coniolariella, and by means of the mitosporic fungal strains from the groups Fusarium, Beauveria and Verticillium (orders Hypocreales and Phyllachorales), and by means of the enzymatic preparations isolated from these fungal strains, and secondly to the use of these strains for the preparation of the abovementioned novel cyclooctadepsipeptides and to the use of bassianolide and of the abovementioned novel cyclooctadepsipeptides individually or as a mixture, as anthelmintics or endoparasiticides.

Abstract: The present invention relates to the use of macrocyclic lactones for treating demodicosis, particularly in dogs.

Abstract: The present invention relates to formulations for the dermal control of parasitic insects on animals, having the following composition agonists or antagonists of the nicotinergic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation; solvents from the group benzyl alcohol or optionally substituted pyrrolidones in a concentration of at least 20% by weight based on the overall weight of the formulation; if desired, further solvents from the group consisting of cyclic carbonates or lactones in a concentration of from 5.0 up to 80% by weight based on the overall weight of the formulation; if desired, further auxiliaries from the group thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, emulsifiers, in a concentration of from 0.025 up to 10% by weight based on the overall weight of the formulation.

Abstract: The present invention relates to formulations for the dermal control of parasitic insects on animals, having the following composition

Abstract: The present invention relates to formulations for the dermal control of parasitic insects of animals, having the following composition agonists or antagonists of the nicotinergic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation; solvents from the group benzyl alcohol or optionally substituted pyrrolidones in a concentration of at least 20% by weight based on the overall weight of the formulation; if desired, further solvents from the group consisting of cyclic carbonates or lactones in a concentration of from 5.0 up to 80% by weight based on the overall weight of the formulation; if desired, further auxiliaries from the group thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, emulsifiers, in a concentration of from 0.025 up to 10% by weight based on the overall weight of the formulation.

Abstract: The present invention relates to formulations for the dermal control of parasitic insects on animals, having the following compositionagonists or antagonists of the nicotinergic acetylcholine receptors of insects in a concentration of from 1 to 20% by weight based on the overall weight of the formulation;solvents from the group benzyl alcohol or optionally substituted pyrrolidones in a concentration of at least 20% by weight based on the overall weight of the formulation;if desired, further solvents from the group consisting of cyclic carbonates or lactones in a concentration of from 5.0 up to 80% by weight based on the overall weight of the formulation;if desired, further auxiliaries from the group thickeners, spreading agents, colorants, antioxidants, propellants, preservatives, adhesives, emulsifiers, in a concentration of from 0.025 up to 10% by weight based on the overall weight of the formulation.